FTC wins $448 million disgorgement from AbbVie and Besins
AbbVie has said it will appeal its loss against the Federal Trade Commission in a lawsuit for monopolising Androgel through sham litigation, as a Pennsylvania federal court ordered the drugmaker and Besins Healthcare to pay $448 million to consumers.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10